HMGA1: A Master Regulator of Tumor Progression in Triple-Negative Breast Cancer Cells

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Shah, Sandeep N ^a   Cope, Leslie ^a   Poh, Weijie ^a   Belton, Amy ^a   Roy, Sujayita ^a   Talbot, C Conover ^a   Sukumar, Saraswati ^a   Huso, David L ^a   Resar, Linda M S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP A PROTEIN; HIGH MOBILITY GROUP A1 PROTEIN; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; E CADHERIN GENE; EMBRYONIC STEM CELL; GENE REPRESSION; HMGA1 GENE; HUMAN; HUMAN CELL; METASTASIS; MOUSE; NONHUMAN; REGULATORY MECHANISM; SNAIL GENE; TRIPLE NEGATIVE BREAST CANCER; TUMOR GROWTH; VIMENTIN GENE;

GASTROPODA;

EID: 84877071501     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063419     Document Type: Article

References (48)

1. Siegel R, Naishadham D, Jemal A, (2013) Cancer statistics. CA Cancer J Clin 63: 11-30.
2. Lee JS, Fackler MJ, Lee JH, Choi C, Park MH, et al. (2010) Basal-like breast cancer displays distinct patterns of promoter methylation. Cancer Biol Ther 9: 1017-1024.
3. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, et al. (2008) An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 40: 499-507.
4. Resar LMS, (2010) The High Mobility Group A1 Gene: Transforming Inflammatory Signals into Cancer? Cancer Research 70: 436-439.
5. Chou B-K, Mali P, Huang X, Ye Z, Dowey S, et al. (2011) Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Res 21: 518-529.
6. Zhou G, Chen J, Lee S, Clark T, Rowley JD, et al. (2001) The pattern of gene expression in human CD34(+) stem/progenitor cells. Proc Natl Acad Sci U S A 98: 13966-13971.
7. Karp JE, Smith BD, Resar LS, Greer JM, Blackford A, et al. (2011) Phase 1 and pharmacokinetic study of bolus-infusion flavopiridol followed by cytosine arabinoside and mitoxantrone for acute leukemias. Blood 117: 3302-3310.
8. Nelson DM, Joseph B, Hillion J, Segal J, Karp JE, et al. (2011) Flavopiridol induces BCL-2 expression and represses oncogenic transcription factors in leukemic blasts from adults with refractory acute myeloid leukemia. Leuk Lymphoma 52: 1999-2006.
9. Schuldenfrei A, Belton A, Kowalski J, Talbot CC, Di Cello F, et al. (2011) HMGA1 Drives Stem Cell, Inflammatory Pathway, and Cell Cycle Progression Genes During Lymphoid Tumorigenesis. BMC Genomics 12: 549.
10. Belton A, Gabrovsky A, Iacobuzio-Donahue C, Huso DL, Resar LMS, (2012) HMGA1 induces intestinal polyposis in transgenic mice and drives tumor progression and stem cell properties in colon cancer cells. PLoS One 7: e30034.
11. Shah SN, Resar LMS, (2012) High Mobility Group A1 and Cancer: Potential Biomarker and Therapeutic Target. Histol Histopathol 27: 567-579.
12. Wood LJ, Mukherjee M, Dolde CE, Xu Y, Maher JF, et al. (2000) HMG-I/Y, a new c-Myc target gene and potential oncogene. Mol Cell Biol 20: 5490-5502.
13. Pedulla ML, Treff NR, Resar LM, Reeves R, (2001) Sequence and analysis of the murine Hmgiy (Hmga1) gene locus. Gene 271: 51-58.
14. Reeves R, Beckerbauer L, (2001) HMGI/Y proteins: flexible regulators of transcription and chromatin structure. Biochim Biophys Acta 1519: 13-29.
15. Reeves R, Edberg DD, Li Y, (2001) Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells. Mol Cell Biol 21: 575-594.
16. Dolde CE, Mukherjee M, Cho C, Resar LMS, (2002) HMG-I/Y in human breast cancer cell lines. Breast Cancer Research and Treatment 71: 181-191.
17. Dhar A, Hu J, Reeves R, Resar LM, Colburn NH, (2004) Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation. Oncogene 23: 4466-4476.
18. Takaha N, Resar LMS, Vindivich D, Coffey DS, (2004) High mobility group protein HMGI(Y) enhances tumor cell growth, invasion, and matrix metalloproteinase-2 expression in prostate cancer cells. The Prostate 60: 160-167.
19. Hommura F, Katabami M, Leaner VD, Donninger H, Sumter TF, et al. (2004) HMG-I/Y is a c-Jun/activator protein-1 target gene and is necessary for c-Jun-induced anchorage-independent growth in Rat1a cells. Mol Cancer Res 2: 305-314.
20. Xu Y, Sumter TF, Bhattacharya R, Tesfaye A, Fuchs EJ, et al. (2004) The HMG-I oncogene causes highly penetrant, aggressive lymphoid malignancy in transgenic mice and is overexpressed in human leukemia. Cancer Res 64: 3371-3375.
21. Tesfaye A, Di Cello F, Hillion J, Ronnett BM, Elbahloul O, et al. (2007) The high-mobility group A1 gene up-regulates cyclooxygenase 2 expression in uterine tumorigenesis. Cancer Res 67: 3998-4004.
22. Fusco A, Fedele M, (2007) Roles of HMGA proteins in cancer. Nat Rev Cancer 7: 899-910.
23. Di Cello F, Hillion J, Kowalski J, Ronnett BM, Aderinto A, et al. (2008) Cyclooxygenase inhibitors block uterine tumorigenesis in HMGA1a transgenic mice and human xenografts. Molecular Cancer Therapeutics 7: 2090-2095.
24. Hillion J, Dhara S, Sumter TF, Mukherjee M, Di Cello F, et al. (2008) The high-mobility group A1a/signal transducer and activator of transcription-3 axis: an achilles heel for hematopoietic malignancies? Cancer Res 68: 10121-10127.
25. Hillion J, Wood LJ, Mukherjee M, Bhattacharya R, Di Cello F, et al. (2009) Upregulation of MMP-2 by HMGA1 promotes transformation in undifferentiated, large-cell lung cancer. Mol Cancer Res 7: 1803-1812.
26. Hristov AC, Cope L, Di Cello F, Reyes MD, Singh M, et al. (2010) HMGA1 correlates with advanced tumor grade and decreased survival in pancreatic ductal adenocarcinoma. Mod Pathol 23: 98-104.
27. Reeves R, (2010) Nuclear functions of HMG proteins. Biochim Biophys Acta 1799: 3-14.
28. Di Cello F, Dhara S, Hristov A, Kowalski J, Elbahloul O, et al. (2013) Inactivation of the Cdkn2a locus cooperates with HMGA1 to drive T-cell leukemogenesis. Leuk Lymphoma [Epub ahead of print].
29. Williams MD, Reeves R, Resar LMS, Hill HH Jr (2013) Metabolomics of colorectal cancer (CRC): Past and current analytical platforms. Anal Bioanal Chem [Epub ahead of print].
30. Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, et al. (2002) Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415: 436-442.
31. Flohr AM, Rogalla P, Bonk U, Puettmann B, Buerger H, et al. (2003) High mobility group protein HMGA1 expression in breast cancer reveals a positive correlation with tumour grade. Histol Histopathol 18: 999-1004.
32. Shah SN, Kerr C, Cope L, Zambidis E, Liu C, et al. (2012) HMGA1 reprograms somatic cells into pluripotent stem cells by inducing stem cell transcriptional networks. PLoS One 7: e48533.
33. Mani SA, Guo W, Liao MJ, Ng E, Ayyanan A, et al. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715.
34. Shaw FL, Harrison H, Spence K, Ablett MP, Simões BM, et al. (2012) A detailed mammosphere assay protocol for the quantification of breast stem cell activity. J Mammary Gland Biol Neoplasia 17: 111-117.
35. Bock C, Kisinis E, Verstappen G, Gu H, Boulting G, et al. (2011) Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 44: 439-452.
36. Muromoto R, Sekine Y, Imoto S, Ikeda O, Okayama T, et al. (2008) BART is essential for nuclear retention of STAT3. Int Immunol 20: 395-403.
37. Massague J, (2008) TGFbeta in cancer. Cell 134: 215-230.
38. Semenza GL (2012) Cancer stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis. Oncogene in press.
39. Thibodeaus CA, Liu X, Disbrow GL, Zhang Y, Rone JD, et al. (2009) Immortalization and transformation of human mammary epithelial cells by a tumor-derived Myc mutant. Breast Cancer Res Treat 116: 281-294.
40. Tront JS, Huang Y, Fornace AJ, Hoffman B, Liebermann D, (2010) Gadd45a functions as a promoter or suppressor of cancer dependent on the oncogenic stress. Cancer Res 70: 9671-9681.
41. Dang CV, (2012) MYC on the path to cancer. Cell 2: 304-307.
42. Nie Z, Hu G, Wei G, Yamane A, Resch A, et al. (2012) c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell 151: 68-79.
43. Liau S-S, Jazag A, Whang EE, (2006) HMGA1a is a determinant of cellular invasiveness & in vitro metastasis in pancreatic adenocarcinoma. Cancer Res 66: 11613-11622.
44. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, et al. (2003) Summaries of Affymetrix GeneChip Probe Level Data. Nucleic Acids Res 31: e15.
45. Carvalho BS, Irizarry RA, (2010) A framework for oligonucleotide microarray preprocessing. Bioinformatics 26: 2363-2367.
46. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80.
47. Smyth GK (2005) Limma: linear models for microarray data, in R. Gentleman; R. V. Carey; S. Dudoit; R. Irizarryconcordance at the top (CAT) plot & W. Huber, eds., 'Bioinformatics and Computational Biology Solutions using R and Bioconductor', Springer-Verlag: 397-420.
48. Barrett T, Suzek TO, Troup DB, Wilhite SE, Ngau W-C, et al. (2005) NCBI GEO: mining millions of expression profiles-database and tools. Nucleic Acids Res 33: D562-D566.